Treatment of hypopituitary children

Journal of Pediatrics

Volumn 144, Issue 4, 2004, Pages 415-416

  Cutler Jr , Gordon B ^a   Chipman, John J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

CANCER INCIDENCE; CANCER RISK; CHILD; CHILDHOOD MORTALITY; COLON CANCER; CREUTZFELDT JAKOB DISEASE; EDITORIAL; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; LONG TERM CARE; PITUITARY DWARFISM; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 1842555254     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2004.02.024     Document Type: Editorial

References (3)

1. Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, Cox C, et al. Long term mortality in the US cohort of pituitary-derived growth hormone recipients. J Pediatr 2004;144:430-6.
2. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958;18:901-3.
3. Swerdlow AJ, Higgins CDE, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 2002;360:273-7.